Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

被引:1230
作者
Falkenberg, Katrina J. [1 ]
Johnstone, Ricky W. [1 ,2 ]
机构
[1] Peter MacCallum Canc Ctr, Canc Therapeut Program, East Melbourne, Vic 3002, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
SUBEROYLANILIDE HYDROXAMIC ACID; TRANS-RETINOIC ACID; CELLS IN-VITRO; SPINAL MUSCULAR-ATROPHY; DOUBLE-STRAND BREAKS; VERSUS-HOST-DISEASE; HDAC INHIBITORS; GENE-EXPRESSION; VALPROIC ACID; EPIGENETIC REGULATION;
D O I
10.1038/nrd4360
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Epigenetic aberrations, which are recognized as key drivers of several human diseases, are often caused by genetic defects that result in functional deregulation of epigenetic proteins, their altered expression and/or their atypical recruitment to certain gene promoters. Importantly, epigenetic changes are reversible, and epigenetic enzymes and regulatory proteins can be targeted using small molecules. This Review discusses the role of altered expression and/or function of one class of epigenetic regulators histone deacetylases (HDACs) - and their role in cancer, neurological diseases and immune disorders. We highlight the development of small-molecule HDAC inhibitors and their use in the laboratory, in preclinical models and in the clinic.
引用
收藏
页码:673 / 691
页数:19
相关论文
共 279 条
[1]   Revisiting the differentiation paradigm in acute promyelocytic leukemia [J].
Ablain, Julien ;
de The, Hugues .
BLOOD, 2011, 117 (22) :5795-5802
[2]   Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy [J].
Ai, T. ;
Cui, H. ;
Chen, L. .
CURRENT MEDICINAL CHEMISTRY, 2012, 19 (04) :475-487
[3]   Histone Deacetylases 1 and 2 Form a Developmental Switch That Controls Excitatory Synapse Maturation and Function [J].
Akhtar, Mohd W. ;
Raingo, Jesica ;
Nelson, Erika D. ;
Montgomery, Rusty L. ;
Olson, Eric N. ;
Kavalali, Ege T. ;
Monteggia, Lisa M. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (25) :8288-8297
[4]   Histone/protein deacetylases and T-cell immune responses [J].
Akimova, Tatiana ;
Beier, Ulf H. ;
Liu, Yujie ;
Wang, Liqing ;
Hancock, Wayne W. .
BLOOD, 2012, 119 (11) :2443-2451
[5]   Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy [J].
Archin, N. M. ;
Liberty, A. L. ;
Kashuba, A. D. ;
Choudhary, S. K. ;
Kuruc, J. D. ;
Crooks, A. M. ;
Parker, D. C. ;
Anderson, E. M. ;
Kearney, M. F. ;
Strain, M. C. ;
Richman, D. D. ;
Hudgens, M. G. ;
Bosch, R. J. ;
Coffin, J. M. ;
Eron, J. J. ;
Hazuda, D. J. ;
Margolis, D. M. .
NATURE, 2012, 487 (7408) :482-U1650
[6]   Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors [J].
Archin, Nancie M. ;
Keedy, Kara S. ;
Espeseth, Amy ;
Dang, Herbert ;
Hazuda, Daria J. ;
Margolis, David M. .
AIDS, 2009, 23 (14) :1799-1806
[7]   Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4 [J].
Backs, Johannes ;
Backs, Thea ;
Bezprozvannaya, Svetlana ;
McKinsey, Timothy A. ;
Olson, Eric N. .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (10) :3437-3445
[8]   Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma [J].
Badros, Ashraf ;
Burger, Angelika M. ;
Philip, Sunita ;
Niesvizky, Ruben ;
Kolla, Sarah S. ;
Goloubeva, Olga ;
Harris, Carolynn ;
Zwiebel, James ;
Wright, John J. ;
Espinoza-Delgado, Igor ;
Baer, Maria R. ;
Holleran, Julianne L. ;
Egorin, Merrill J. ;
Grant, Steven .
CLINICAL CANCER RESEARCH, 2009, 15 (16) :5250-5257
[9]   A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas [J].
Balasubramanian, S. ;
Ramos, J. ;
Luo, W. ;
Sirisawad, M. ;
Verner, E. ;
Buggy, J. J. .
LEUKEMIA, 2008, 22 (05) :1026-1034
[10]   Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors [J].
Bali, P ;
Pranpat, M ;
Bradner, J ;
Balasis, M ;
Fiskus, W ;
Guo, F ;
Rocha, K ;
Kumaraswamy, S ;
Boyapalle, S ;
Atadja, P ;
Seto, E ;
Bhalla, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) :26729-26734